Takayuki Hishiki
Overview
Explore the profile of Takayuki Hishiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, et al.
NEJM Evid
. 2024 Feb;
3(3):EVIDoa2300290.
PMID: 38411447
BACKGROUND: Vaccination against mpox (formerly known as monkeypox), an infectious disease caused by the monkeypox virus (MPXV), is needed to prevent outbreaks and consequent public health concerns. The LC16m8 vaccine,...
2.
Kurosawa M, Kato F, Hishiki T, Ito S, Fujisawa H, Yamaguchi T, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396699
Dengue virus (DENV) causes dengue fever and dengue hemorrhagic fever, and DENV infection kills 20,000 people annually worldwide. Therefore, the development of anti-DENV drugs is urgently needed. Sofosbuvir (SOF) is...
3.
Hossain K, Akhter R, Rashid M, Akter L, Utsunomiya M, Kitab B, et al.
Virus Res
. 2023 Oct;
339:199244.
PMID: 37832653
Dengue virus (DENV) is mainly found in the tropics and infects approximately 400 million people annually. However, no clinically available therapeutic agents specific to dengue have been developed. Here, we...
4.
Kawakami E, Saiki N, Yoneyama Y, Moriya C, Maezawa M, Kawamura S, et al.
Cell Stem Cell
. 2023 Oct;
30(10):1315-1330.e10.
PMID: 37802037
COVID-19 is linked to endotheliopathy and coagulopathy, which can result in multi-organ failure. The mechanisms causing endothelial damage due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain elusive. Here,...
5.
Hishiki T, Morita T, Akazawa D, Ohashi H, Park E, Kataoka M, et al.
Microbiol Spectr
. 2023 Jul;
11(4):e0056623.
PMID: 37409948
Mpox virus (formerly monkeypox virus [MPXV]) is a neglected zoonotic pathogen that caused a worldwide outbreak in May 2022. Given the lack of an established therapy, the development of an...
6.
Akazawa D, Ohashi H, Hishiki T, Morita T, Iwanami S, Kim K, et al.
J Infect Dis
. 2023 Mar;
228(5):591-603.
PMID: 36892247
Background: Mpox virus (MPXV) is a zoonotic orthopoxvirus and caused an outbreak in 2022. Although tecovirimat and brincidofovir are approved as anti-smallpox drugs, their effects in mpox patients have not...
7.
Watanabe Y, Suzuki Y, Emi A, Murakawa T, Hishiki T, Kato F, et al.
Biochem Biophys Res Commun
. 2022 Nov;
637:181-188.
PMID: 36403481
The Chikungunya virus (CHIKV), an enveloped RNA virus that has been identified in over 40 countries and is considered a growing threat to public health worldwide. However, there is no...
8.
Ohishi T, Hishiki T, Baig M, Rajpoot S, Saqib U, Takasaki T, et al.
PLoS One
. 2022 Jul;
17(7):e0271112.
PMID: 35830431
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This...
9.
Ohashi H, Hishiki T, Akazawa D, Kim K, Woo J, Shionoya K, et al.
Antiviral Res
. 2022 Jul;
205:105372.
PMID: 35798223
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 has spread in many countries, replacing the earlier Omicron subvariant BA.1 and other variants. Here, using a cell culture...
10.
Kato F, Nakatsu Y, Murano K, Wakata A, Kubota T, Hishiki T, et al.
Front Microbiol
. 2021 Dec;
12:751909.
PMID: 34867872
Many efforts have been dedicated to the discovery of antiviral drug candidates against the mumps virus (MuV); however, no specific drug has yet been approved. The development of efficient screening...